Marabueno, Stella .

HRN: 26-72-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2025
CEFUROXIME 750MG (VIAL)
02/17/2025
02/24/2025
IV
450mg
Q8
BCF Sec. To ARTI
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  URTIBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: